Company: DAWN
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0000950170-25-064436
Chunk: 6

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Item 1
Chunk 6
---
 2025 and December 31, 2024, respectively

     10

     10

     Additional paid-in-capital

     1,069,631

     1,056,738

     Accumulated other comprehensive income

     (52
     )

     84

     Accumulated deficit

     (590,077
     )

     (554,081
     )

     Total stockholders’ equity

     479,512

     502,751

     Total liabilities and stockholders' equity
      
     $
     534,356

     $
     582,788

See accompanying notes to the condensed financial statements. 

4